M. Marescotti

发表

Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and Montpellier

L. Magni, C. Cobelli, G. De Nicolao, 2009, Journal of diabetes science and technology.

Combination of continuous subcutaneous infusion of insulin and octreotide in Type 1 diabetic patients.

D. Bruttomesso, M. Marescotti, A. Tiengo, 2001, Diabetes research and clinical practice.

Mechanism(s) of the blood glucose lowering action of benfluorex.

M. Marescotti, A. Tiengo, S. Del Prato, 1993, Diabetes/metabolism reviews.

Flow‐regulated glucose and lipid metabolism in adipose tissue, endothelial cell and hepatocyte cultures in a modular bioreactor

A. Ahluwalia, M. Marescotti, A. Avogaro, 2010, Biotechnology journal.

Glucose and Fatty Acid Metabolism in a 3 Tissue In-Vitro Model Challenged with Normo- and Hyperglycaemia

Arti Ahluwalia, Elisabetta Iori, Angelo Avogaro, 2012, PloS one.

Elevated white blood cell count is associated with prevalence and development of the metabolic syndrome and its components in the general population

M. Marescotti, A. Avogaro, G. Fadini, 2012, Acta Diabetologica.

Mechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients.

M. Marescotti, A. Avogaro, A. Tiengo, 1993, Metabolism: clinical and experimental.

Mechanisms of acute and chronic hypoglycemic action of gliclazide

A. Maran, M. Marescotti, A. Tiengo, 2000, Acta Diabetologica.

Surgical removal of insulinoma restores glucose recovery from hypoglycaemia but does not normalize insulin action

M. Marescotti, A. Avogaro, A. Tiengo, 1995, European journal of clinical investigation.

Intermediary metabolite profiles during euglycemic glucose-insulin clamp: Effects of ethanol

M. Marescotti, A. Avogaro, A. Tiengo, 1986, La Ricerca in clinica e in laboratorio.

Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism.

G. Biolo, M. Marescotti, A. Tiengo, 1986, The Journal of clinical investigation.

FreeStyle Libre and Dexcom G4 Platinum sensors: Accuracy comparisons during two weeks of home use and use during experimentally induced glucose excursions.

D. Bruttomesso, M. Marescotti, A. Avogaro, 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial

M. Marescotti, A. Avogaro, G. Fadini, 2017, Cardiovascular Diabetology.

Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy

M. Marescotti, A. Avogaro, A. Tiengo, 1983, Diabetologia.

NETosis Delays Diabetic Wound Healing in Mice and Humans

F. Mammano, M. Marescotti, A. Avogaro, 2016, Diabetes.

Circulating Stem Cells Associate With Adiposity and Future Metabolic Deterioration in Healthy Subjects.

M. Marescotti, A. Avogaro, X. Durán, 2015, The Journal of clinical endocrinology and metabolism.

Acute Effects of Linagliptin on Progenitor Cells, Monocyte Phenotypes, and Soluble Mediators in Type 2 Diabetes.

M. Marescotti, A. Avogaro, G. Fadini, 2016, The Journal of clinical endocrinology and metabolism.

Development of metabolic syndrome and electrocardiographic features of left ventricular hypertrophy in middle-aged working subjects

M. Marescotti, A. Avogaro, G. Fadini, 2013, Journal of Endocrinological Investigation.

Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients.

M. Marescotti, A. Avogaro, M. Plebani, 2015, Vascular pharmacology.

Moderate alcohol consumption, glucose metabolism and lipolysis: the effect on adiponectin and tumor necrosis factor α

M. Marescotti, A. Avogaro, A. Tiengo, 2003 .

Defective Suppression byInsulin ofLeucine-Carbon Appearance and Oxidation inType1,Insulin-dependent Diabetes Mellitus Evidence forInsulin Resistance Involving GlucoseandAminoAcidMetabolism

M. Marescotti, 1986 .

No effects of high-fiber diets on metabolic control and insulin-sensitivity in type 1 diabetic subjects.

G. Biolo, D. Bruttomesso, M. Marescotti, 1991, Diabetes research and clinical practice.

The rs2274911 polymorphism in GPRC6A gene is associated with insulin resistance in normal weight and obese subjects

M. Marescotti, A. Avogaro, M. Plebani, 2017, Clinical endocrinology.

Leucine kinetics and the effects of hyperinsulinemia in patients with Cushing's syndrome.

G. Biolo, M. Marescotti, A. Tiengo, 1989, The Journal of clinical endocrinology and metabolism.

Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in vivo. Evidence for distinct mechanisms in regulation of net amino acid deposition.

Del, Gaetano, G. Biolo, 1987, The Journal of clinical investigation.

Insulin-induced glucose control improves HDL cholesterol levels but not reverse cholesterol transport in type 2 diabetic patients.

M. Marescotti, A. Avogaro, G. Fadini, 2014, Atherosclerosis.

Diabetes Impairs Stem Cell and Proangiogenic Cell Mobilization in Humans

M. Marescotti, A. Avogaro, G. Fadini, 2013, Diabetes Care.

In situ protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy

M. Marescotti, A. Avogaro, A. Tiengo, 2003, Diabetologia.

Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.

D. Bruttomesso, M. Marescotti, A. Avogaro, 1999, Diabetes.

Head-to-head comparison of the accuracy of Abbott FreeStyle Libre and Dexcom G5 mobile.

Andrea Facchinetti, G. Acciaroli, Angelo Avogaro, 2018, Nutrition, metabolism, and cardiovascular diseases : NMCD.

A Polymorphism at the IL6ST (gp130) Locus Is Associated With Traits of the Metabolic Syndrome

M. Marescotti, A. Avogaro, A. Doria, 2008, Obesity.

Genetic variability at the leptin receptor (LEPR) locus is a determinant of plasma fibrinogen and C-reactive protein levels.

C. Mantzoros, M. Marescotti, A. Avogaro, 2007, Atherosclerosis.

Optimized glycaemic control achieved with add‐on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine

M. Marescotti, A. Avogaro, A. Tiengo, 2011, Diabetes, obesity & metabolism.

A Visfatin Promoter Polymorphism Is Associated with Low‐Grade Inflammation and Type 2 Diabetes

M. Marescotti, A. Avogaro, A. Doria, 2006, Obesity.

Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes

D. Bruttomesso, M. Marescotti, A. Avogaro, 2019, Journal of Endocrinological Investigation.

Synergistic interactions among metabolic syndrome components and homeostasis model assessment of insulin resistance in a middle-aged general population over time.

M. Marescotti, A. Avogaro, G. Fadini, 2015, Metabolic syndrome and related disorders.

Effect of different times of administration of a single ethanol dose on insulin action, insulin secretion and redox state

G. Pacini, M. Marescotti, M. Vettore, 1999, Diabetic medicine : a journal of the British Diabetic Association.

Systemic and vascular inflammation in an in-vitro model of central obesity

M. Marescotti, A. Avogaro, F. Vozzi, 2017, bioRxiv.